Hinge-deficient IgG1 Fc fusion: Application to human lactoferrin

作者: Yuki Shiga , Daisuke Murata , Akinori Sugimoto , Yuta Oshima , Minoru Tada

DOI: 10.1021/ACS.MOLPHARMACEUT.7B00221

关键词:

摘要: Fusion of therapeutic proteins with the antibody Fc domain is a strategy widely applied to increase protein half-life in plasma. In our previous study, we generated recombinant human lactoferrin (hLF)-immunoglobulin G1 fusion (hLF-hinge-CH2-CH3) improved stability, biological activity, and pharmacokinetics (Shiga, Y. et al. Eur J Pharm Sci., 2015, 67, 136––143). However, can potentially induce antibody-dependent complement-dependent cytotoxicity serious side effects. To overcome these drawbacks, engineered an hLF-Fc (hLF-CH2-CH3) without hinge region which essential for engaging receptors on immune cells inducing complement-mediated cell lysis. The hLF-CH2-CH3 was stably expressed Chinese hamster ovary (CHO) DG44 compared vitro activities, thermal pharmacokinetics, attenuation Fc-mediated effector functions conventional hinge-containing prote...

参考文章(50)
Daniel M. Czajkowsky, Jun Hu, Zhifeng Shao, Richard J. Pleass, Fc‐fusion proteins: new developments and future perspectives Embo Molecular Medicine. ,vol. 4, pp. 1015- 1028 ,(2012) , 10.1002/EMMM.201201379
Yuki Ogasawara, Megumi Imase, Hirotsugu Oda, Hiroyuki Wakabayashi, Kazuyuki Ishii, Lactoferrin Directly Scavenges Hydroxyl Radicals and Undergoes Oxidative Self-Degradation: A Possible Role in Protection against Oxidative DNA Damage International Journal of Molecular Sciences. ,vol. 15, pp. 1003- 1013 ,(2014) , 10.3390/IJMS15011003
MARTINE I. BAZIN-REDUREAU, CATHERINE B. RENARD, JEAN-MICHEL G. SCHERRMANN, Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab')2 and Fab after intravenous administration in the rat Journal of Pharmacy and Pharmacology. ,vol. 49, pp. 277- 281 ,(2011) , 10.1111/J.2042-7158.1997.TB06795.X
Tomoji Ono, Satoru Morishita, Chikako Fujisaki, Motoyasu Ohdera, Michiaki Murakoshi, Norio Iida, Hisanori Kato, Kazuo Miyashita, Masaaki Iigo, Toshihide Yoshida, Keikichi Sugiyama, Hoyoku Nishino, Effects of pepsin and trypsin on the anti-adipogenic action of lactoferrin against pre-adipocytes derived from rat mesenteric fat British Journal of Nutrition. ,vol. 105, pp. 200- 211 ,(2011) , 10.1017/S0007114510003259
S. Ramalingam, J. Crawford, A. Chang, C. Manegold, R. Perez-Soler, J.-Y. Douillard, N. Thatcher, F. Barlesi, T. Owonikoko, Y. Wang, P. Pultar, J. Zhu, R. Malik, G. Giaccone, S. Della-Fiorentina, S. Begbie, R. Jennens, J. Dass, K. Pittman, N. Ivanova, T. Koynova, P. Petrov, A. Tomova, V. Tzekova, F. Couture, V. Hirsh, R. Burkes, R. Sangha, M. Ambrus, T. Janaskova, J. Musil, J. Novotny, P. Zatloukal, J. Jakesova, K. Klenha, J. Roubec, J. Vanasek, J. Fayette, F. Barlesi, J. Bennouna-Louridi, C. Chouaid, J. Mazières, H. Vallerand, G. Robinet, P.-J. Souquet, D. Spaeth, R. Schott, H. Lena, Y. Martinet, C. El Kouri, N. Baize, A. Scherpereel, O. Molinier, F. Fuchs, K.M. Josten, C. Manegold, N. Marschner, F. Schneller, T. Overbeck, M. Thomas, J. von Pawel, M. Reck, W. Schuette, V. Hagen, C.-P. Schneider, V. Georgoulias, I. Varthalitis, K. Zarogoulidis, K. Syrigos, C. Papandreou, C. Bocskei, E. Csanky, E. Juhasz, G. Losonczy, Z. Mark, I. Molnar, Z. Papai-Szekely, S. Tehenes, I. Vinkler, S. Almel, A. Bakshi, S. Bondarde, A. Maru, A. Pathak, R.M. Pedapenki, K. Prasad, S.V.S.S. Prasad, N. Kilara, D. Gorijavolu, C.D. Deshmukh, S. John, L.M. Sharma, D. Amoroso, E. Bajetta, P. Bidoli, A. Bonetti, F. De Marinis, M. Maio, R. Passalacqua, S. Cascinu, A. Bearz, M. Bitina, A. Brize, G. Purkalne, M. Skrodele, A.A. Baba, K. Ratnavelu, M.H. Saw, M.C. Samson-Fernando, G.E. Ladrera, J. Jassem, P. Koralewski, P. Serwatowski, M. Krzakowski, C. Cebotaru, D. Filip, D.E. Ganea-Motan, C.H. Ianuli, I.G. Manolescu, A. Udrea, O. Burdaeva, M. Byakhov, A. Filippov, S. Lazarev, I. Mosin, S. Orlov, D. Udovitsa, A. Khorinko, S. Protsenko, A. Chang, H.L. Lim, Y.O. Tan, E.H. Tan, R. Bastus Piulats, J. Garcia-Foncillas, J. Valdivia, J. de Castro, M. Domine Gomez, S.W. Kim, J.-S. Lee, H.K. Kim, J.S. Lee, S.W. Shin, D.-W. Kim, Y.-C. Kim, K.C. Park, C.-S. Chang, G.-C. Chang, Y.-G. Goan, W.-C. Su, C.-M. Tsai, H.-P. Kuo, M. Benekli, G. Demir, E. Gokmen, A. Sevinc, J. Crawford, G. Giaccone, M. Haigentz, T. Owonikoko, M. Agarwal, S. Pandit, R. Araujo, N. Vrindavanam, P. Bonomi, A. Berg, J. Wade, R. Bloom, B. Amin, R. Camidge, D. Hill, M. Rarick, P. Flynn, L. Klein, K. Lo Russo, M. Neubauer, P. Richards, R. Ruxer, M. Savin, D. Weckstein, R. Rosenberg, T. Whittaker, D. Richards, W. Berry, C. Ottensmeier, A. Dangoor, N. Steele, Y. Summers, E. Rankin, K. Rowley, S. Giridharan, H. Kristeleit, C. Humber, P. Taylor, Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial) Annals of Oncology. ,vol. 24, pp. 2875- 2880 ,(2013) , 10.1093/ANNONC/MDT371
Gestur Vidarsson, Gillian Dekkers, Theo Rispens, IgG Subclasses and Allotypes: From Structure to Effector Functions Frontiers in Immunology. ,vol. 5, pp. 520- 520 ,(2014) , 10.3389/FIMMU.2014.00520
Atsushi Ishikado, Hiromichi Imanaka, Mayumi Kotani, Akihito Fujita, Yoko Mitsuishi, Tomoyuki Kanemitsu, Yoshiko Tamura, Taketoshi Makino, Liposomal lactoferrin induced significant increase of the interferon‐alpha (IFN‐α) producibility in healthy volunteers Biofactors. ,vol. 21, pp. 69- 72 ,(2004) , 10.1002/BIOF.552210113
Dominique Legrand, Overview of Lactoferrin as a Natural Immune Modulator The Journal of Pediatrics. ,vol. 173, ,(2016) , 10.1016/J.JPEDS.2016.02.071
Y. A. Suzuki, V. Lopez, B. Lönnerdal, Mammalian lactoferrin receptors: structure and function. Cellular and Molecular Life Sciences. ,vol. 62, pp. 2560- 2575 ,(2005) , 10.1007/S00018-005-5371-1
Francesco Giansanti, Gloria Panella, Loris Leboffe, Giovanni Antonini, Lactoferrin from Milk: Nutraceutical and Pharmacological Properties. Pharmaceuticals. ,vol. 9, pp. 61- 76 ,(2016) , 10.3390/PH9040061